Satoshi Kuwabara

Research interests

Publications

• Guillain-Barré syndrome

  The Lancet · 2021 · 10.1016/s0140-6736(21)00517-1

• European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision

  European Journal of Neurology · 2021 · 10.1111/ene.14959

• European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision

  Journal of the Peripheral Nervous System · 2021 · 10.1111/jns.12455

• Standards of instrumentation of EMG

  Clinical Neurophysiology · 2019 · 10.1016/j.clinph.2019.07.025

• Chronic inflammatory demyelinating polyneuropathy: update on diagnosis, immunopathogenesis and treatment

  Journal of Neurology Neurosurgery & Psychiatry · 2019 · 10.1136/jnnp-2019-320314

• Diagnosis and Treatment of NMO Spectrum Disorder and MOG-Encephalomyelitis

  Frontiers in Neurology · 2018 · 10.3389/fneur.2018.00888

• Regional variation of Guillain-Barré syndrome

  Brain · 2018 · https://doi.org/10.1093/brain/awy232

• Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial

  The Lancet Neurology · 2017 · 10.1016/s1474-4422(17)30378-2

• Nodopathies of the peripheral nerve: an emerging concept

  Journal of Neurology Neurosurgery & Psychiatry · 2015 · 10.1136/jnnp-2014-310097

• TDP-43 pathology and neuronal loss in amyotrophic lateral sclerosis spinal cord

  Acta Neuropathologica · 2014 · 10.1007/s00401-014-1299-6

• Axonal Guillain-Barré syndrome: concepts and controversies

  The Lancet Neurology · 2013 · 10.1016/s1474-4422(13)70215-1

• Different neurological and physiological profiles in POEMS syndrome and chronic inflammatory demyelinating polyneuropathy

  Journal of Neurology Neurosurgery & Psychiatry · 2012 · 10.1136/jnnp-2011-301706

• Electrodiagnostic criteria for Guillain–Barrè syndrome: A critical revision and the need for an update

  Clinical Neurophysiology · 2012 · 10.1016/j.clinph.2012.01.025

• Ultrasonographic detection of fasciculations markedly increases diagnostic sensitivity of ALS

  Neurology · 2011 · 10.1212/wnl.0b013e318233b36a

• Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6

  Multiple Sclerosis Journal · 2010 · 10.1177/1352458510379247

• Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET

  Neurology · 2009 · 10.1212/wnl.0b013e3181ab2b58

• Bickerstaff's brainstem encephalitis and Fisher syndrome form a continuous spectrum

  Journal of Neurology · 2008 · 10.1007/s00415-008-0775-0

• Gangliosides contribute to stability of paranodal junctions and ion channel clusters in myelinated nerve fibers

  Glia · 2007 · 10.1002/glia.20503

• Altered axonal excitability properties in amyotrophic lateral sclerosis: impaired potassium channel function related to disease stage

  Brain · 2006 · 10.1093/brain/awl024

• Guillain-Barr?? Syndrome

  Drugs · 2004 · 10.2165/00003495-200464060-00003

• Bickerstaff’s brainstem encephalitis: clinical features of 62 cases and a subgroup associated with Guillain–Barré syndrome

  Brain · 2003 · 10.1093/brain/awg233

• Clinical features and prognosis of Miller Fisher syndrome

  Neurology · 2001 · 10.1212/wnl.56.8.1104

• Axonal Guillain-Barr� syndrome: Relation to anti-ganglioside antibodies andCampylobacter jejuni infection in Japan

  Annals of Neurology · 2000 · 10.1002/1531-8249(200010)48:4<624::aid-ana9>3.0.co;2-o

• Axonal Guillain‐Barré syndrome: Relation to anti‐ganglioside antibodies and Campylobacter jejuni infection in Japan

  Annals of Neurology · 2000 · 10.1002/1531-8249(200010)48:4<624::aid-ana9>3.3.co;2-f

• Axonal Guillain‐Barré syndrome: Relation to anti‐ganglioside antibodies and Campylobacter jejuni infection in Japan

  Annals of Neurology · 2000 · 10.1002/1531-8249(200010)48:4<624::aid-ana9>3.3.co;2-f

• Axonal Guillain‐Barré syndrome: Relation to anti‐ganglioside antibodies and Campylobacter jejuni infection in Japan

  Annals of Neurology · 2000 · 10.1002/1531-8249(200010)48:4<624::aid-ana9>3.3.co;2-f

• IgG Anti‐GM1 antibody is associated with reversible conduction failure and axonal degeneration in guillain‐barré syndrome

  Annals of Neurology · 1998 · 10.1002/ana.410440210

Current projects

No projects listed.